ReviewClinical rheumatology2026

Potential of chimeric antigen receptor (CAR) T cell immunotherapy in systemic lupus erythematosus (SLE).

Ian C Chikanza et al.PubMed ↗Publisher ↗

No numbers read from the abstract.